MPL and COVID-19: Moreover, drugs such as romiplostim acting as an agonist for the thrombopoietin receptor are also predicted to be useful to treat COVID-19-associated thrombocytopenia, in agreement with a recent case study documenting platelet recovery following treatment with this drug of a COVID-19 pediatric patient [54].